scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1365-2362.1992.TB01482.X |
P698 | PubMed publication ID | 1633836 |
P2093 | author name string | Mustajoki P | |
Tenhunen R | |||
Matikainen E | |||
Seppäläinen AM | |||
Timonen K | |||
Gorchein A | |||
P2860 | cites work | Repression of the Overproduction of Porphyrin Precursors in Acute Intermittent Porphyria by Intravenous Infusions of Hematin | Q37491123 |
Effect of hematin in porphyric neuropathy | Q40113953 | ||
Neuropharmacology of delta-aminolaevulinic acid. II. Effect of chronic administration in mice | Q41578390 | ||
Determination of delta-aminolaevulinic acid in biological fluids by gas-liquid chromatography with electron-capture detection | Q42868310 | ||
Tissue uptake of o-aminolaevulinic acid | Q44800562 | ||
Determination of delta-aminolevulinic acid in plasma | Q45213072 | ||
Effects of haem arginate on variegate porphyria | Q46120537 | ||
P433 | issue | 6 | |
P304 | page(s) | 407-411 | |
P577 | publication date | 1992-06-01 | |
P1433 | published in | European Journal of Clinical Investigation | Q15745208 |
P1476 | title | Sustained high plasma 5-aminolaevulinic acid concentration in a volunteer: no porphyric symptoms | |
P478 | volume | 22 |
Q34520894 | Biochemical characterization of porphobilinogen deaminase-deficient mice during phenobarbital induction of heme synthesis and the effect of enzyme replacement |
Q73822695 | Effects of fractionated 5-aminolevulinic acid administration on tissue levels of protoporphyrin in vivo |
Q45248914 | Fluorescence imaging technique: diagnostic and therapeutic interest in gynecology |
Q92046226 | Heme biosynthesis and the porphyrias |
Q28200784 | Heme deficiency in Alzheimer's disease: a possible connection to porphyria |
Q54133753 | Hemodynamic effects of 5-aminolevulinic acid in humans |
Q42478276 | Mitochondrial energetic defects in muscle and brain of a Hmbs-/- mouse model of acute intermittent porphyria |
Q33849564 | Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria |
Q35976204 | Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy |
Q36850059 | Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues |
Q42546478 | Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood |
Q35210457 | Photodynamic therapy for pancreatic carcinoma: experimental and clinical studies. |
Q36080027 | Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer--prolonged animal survival |
Q34407455 | Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study |
Q73095011 | Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid |
Q89563680 | Preanesthetic severe postural hypotension following 5-aminolevulinic acid pretreatment in patients for photodynamic diagnosis-assisted urological surgery |
Q33610809 | The cutaneous porphyrias: a review. The British Photodermatology Group |
Q73458945 | The importance of fluorescence distribution and kinetics of ALA-induced PpIX in the bladder in photodynamic therapy |